Antibody Engineering and Antibody Therapeutics Annual Meeting 2012

Dedicated to Delivering Scientific Research & Clinical Results

The world's most respected protein engineering and science meeting just got even better! Now in its 23rd year, this true scientific program covers the full spectrum of challenges in this space from basic science through clinical development.

Dedicated to Delivering Scientific Research & Clinical Results So You Can Optimize Your Engineering Strategies

NEW PROGRAMMING to Track Emerging Trends in the Field:
• Develop Next-Generation Immunomodulatory Antibodies
• Expand Antibody Targeting with Combinations and Bispecifics
• Cross the Blood Brain Barrier to Develop Antibody-Targeted CNS Therapies
• Extend Antibody Half-Life for Improved Efficacy and PK/PD
• Apply Next Generation DNA Sequencing to Accelerate Antibody Research
• Navigate Recent IP Changes Impacting Antibody Research